We found that xenografts derived from co-transplantation with CAFs resulted in enhanced tumor volume and tumor weight compared with xenografts derived from A549 cells alone, suggesting that CAFs promoted NSCLC progression (Fig. 5B, and Fig. S7A). Here, TBX1 is linked to non-small cell lung carcinoma.